136 related articles for article (PubMed ID: 22578139)
1. Factor XIII Val34Leu polymorphism is associated with increased factor XIII activation and decreased transcutaneous oxygen readings in patients with diabetic foot ulcers.
Küper MA; Schüle R; Mayer P; Königsrainer A; Beckert S
Diabet Med; 2012 Dec; 29(12):1596-9. PubMed ID: 22578139
[TBL] [Abstract][Full Text] [Related]
2. The effect of the Val34Leu polymorphism in the factor XIII gene in infants with a birth weight below 1500 g.
Göpel W; Kattner E; Seidenberg J; Kohlmann T; Segerer H; Möller J;
J Pediatr; 2002 Jun; 140(6):688-92. PubMed ID: 12072871
[TBL] [Abstract][Full Text] [Related]
3. The homozygous leu variant of the factor XIII Val34Leu polymorphism as a risk factor for the manifestation of thrombotic microangiopathies.
Sucker C; Farokhzad F; Kurschat C; Grabensee B; Scharf RE; Zotz RB; Maruhn-Debowski B; Hetzel GR
Clin Appl Thromb Hemost; 2009; 15(2):197-200. PubMed ID: 17895511
[TBL] [Abstract][Full Text] [Related]
4. Factor XIII Val34Leu variant and the risk of myocardial infarction: a meta-analysis.
Shafey M; Anderson JL; Scarvelis D; Doucette SP; Gagnon F; Wells PS
Thromb Haemost; 2007 Apr; 97(4):635-41. PubMed ID: 17393027
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of factor XIII Val34Leu polymorphism in patients affected by spontaneous subconjunctival hemorrhage.
Parmeggiani F; Costagliola C; Incorvaia C; Gemmati D; D'Angelo S; Tognazzo S; Scapoli GL; Sebastiani A
Am J Ophthalmol; 2004 Sep; 138(3):481-4. PubMed ID: 15364237
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of the coagulation factor XIII polymorphism Val34Leu in women with recurrent miscarriage.
López Ramírez Y; Vivenes M; Miller A; Pulido A; López Mora J; Arocha-Piñango CL; Marchi R
Clin Chim Acta; 2006 Dec; 374(1-2):69-74. PubMed ID: 16844105
[TBL] [Abstract][Full Text] [Related]
7. Factor XIII Val34Leu polymorphism in patients with cardiac syndrome X.
Güler GB; Batgerel U; Güler E; Karaca O; Geçmen C; Güneş HM; Aguş HZ; Esen AM; Türkmen MM
Cardiol J; 2014; 21(1):6-10. PubMed ID: 23677728
[TBL] [Abstract][Full Text] [Related]
8. The Val34Leu genetic variation in the A subunit of coagulation factor XIII in recurrent spontaneous abortion.
Bagheri M; Rad IA; Omrani MD; Nanbaksh F
Syst Biol Reprod Med; 2011 Oct; 57(5):261-4. PubMed ID: 21548851
[TBL] [Abstract][Full Text] [Related]
9. Decreased factor XIII levels in factor XIII A subunit Leu34 homozygous patients with coronary artery disease.
Bereczky Z; Balogh E; Katona E; Czuriga I; Kárpáti L; Shemirani AH; Edes I; Muszbek L
Thromb Res; 2008; 121(4):469-76. PubMed ID: 17597187
[TBL] [Abstract][Full Text] [Related]
10. Coagulation factor XIII VaI34Leu polymorphism in patients with small vessel disease or primary intracerebral hemorrhage.
Slowik A; Dziedzic T; Pera J; Figlewicz DA; Szczudlik A
Cerebrovasc Dis; 2005; 19(3):165-70. PubMed ID: 15644629
[TBL] [Abstract][Full Text] [Related]
11. Role of factor XIII Val34Leu polymorphism in retinal artery occlusion.
Weger M; Renner W; Stanger O; Schmut O; Deutschmann H; Wascher TC; Haas A
Stroke; 2001 Dec; 32(12):2759-61. PubMed ID: 11739969
[TBL] [Abstract][Full Text] [Related]
12. The association between the Val34Leu polymorphism in the factor XIII gene and brain infarction.
Elbaz A; Poirier O; Canaple S; Chédru F; Cambien F; Amarenco P
Blood; 2000 Jan; 95(2):586-91. PubMed ID: 10627467
[TBL] [Abstract][Full Text] [Related]
13. The factor XIII-A Val34Leu polymorphism decreases whole blood clot mass at high fibrinogen concentrations.
Kattula S; Bagoly Z; Tóth NK; Muszbek L; Wolberg AS
J Thromb Haemost; 2020 Apr; 18(4):885-894. PubMed ID: 31989767
[TBL] [Abstract][Full Text] [Related]
14. A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarction.
Marín F; González-Conejero R; Lee KW; Corral J; Roldán V; López F; Sogorb F; Caturla J; Lip GY; Vicente V
J Am Coll Cardiol; 2005 Jan; 45(1):25-9. PubMed ID: 15629368
[TBL] [Abstract][Full Text] [Related]
15. Factor XIII Val34Leu polymorphism, factor XIII antigen levels and activity and the risk of deep venous thrombosis.
Van Hylckama Vlieg A; Komanasin N; Ariëns RA; Poort SR; Grant PJ; Bertina RM; Rosendaal FR
Br J Haematol; 2002 Oct; 119(1):169-75. PubMed ID: 12358922
[TBL] [Abstract][Full Text] [Related]
16. Factor XIII Val34Leu polymorphism modulates the prothrombotic and inflammatory state associated with atrial fibrillation.
Marín F; Corral J; Roldán V; González-Conejero R; del Rey ML; Sogorb F; Lip GY; Vicente V
J Mol Cell Cardiol; 2004 Sep; 37(3):699-704. PubMed ID: 15350843
[TBL] [Abstract][Full Text] [Related]
17. Association of the F13A1 Val34Leu polymorphism and recurrent pregnancy loss: A meta-analysis.
Jung JH; Kim JH; Song GG; Choi SJ
Eur J Obstet Gynecol Reprod Biol; 2017 Aug; 215():234-240. PubMed ID: 28683377
[TBL] [Abstract][Full Text] [Related]
18. Lack of evidence for association between factor XIII-A Val34Leu polymorphism and ischemic stroke: a meta-analysis of 8,800 subjects.
Li B; Zhang L; Yin Y; Pi Y; Yang Q; Gao C; Fang C; Wang J; Li J
Thromb Res; 2012 Oct; 130(4):654-60. PubMed ID: 22154241
[TBL] [Abstract][Full Text] [Related]
19. Val34Leu factor XIII polymorphism in Italian patients with inflammatory bowel disease.
Saibeni S; Vecchi M; Faioni EM; Franchi F; Rondonotti E; Borsi G; de Franchis R
Dig Liver Dis; 2003 Jan; 35(1):32-6. PubMed ID: 12725605
[TBL] [Abstract][Full Text] [Related]
20. Genetic association between FXIII and β-fibrinogen genes and women with recurrent spontaneous abortion: a meta- analysis.
Li J; Wu H; Chen Y; Wu H; Xu H; Li L
J Assist Reprod Genet; 2015 May; 32(5):817-25. PubMed ID: 25862345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
